Back to search
FDAFDA · Food and drugs·Recall number Z-2639-2017

DeRoyal(R) Dolphin Inflation Device, REF 0185ND, Rx Only, STERILE EO, Dolphin is an inflation device indicated during angioplasty procedures to inflate and deflate the balloon catheter, and control pressure.

Published July 5, 2017 · Recall initiated: June 7, 2017

Summary

FDA records medical device Class II recall Z-2639-2017, published July 5, 2017 and initiated June 7, 2017. Recalling firm: DeRoyal Industries Inc; Status: Terminated; Reported quantity: 426 units; Lot: Lot Number 15125173. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance. There is a defect in the primary packaging of the device, which may compromise the device sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DeRoyal Industries Inc
Distributor
Nationwide Distribution to MD, NY, and IL
Lot
Lot Number 15125173
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was DeRoyal(R) Dolphin Inflation Device, REF 0185ND, Rx Only, STERILE EO, Dolphin is an inflation device indicated during angioplasty procedures to inflate and deflate the balloon catheter, and control pressure. recalled?

Yes. FDA published recall Z-2639-2017 on July 5, 2017. Reported hazard: Lack of sterility assurance. There is a defect in the primary packaging of the device, which may compromise the device sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter